Rates of hospitalization for community-acquired pneumonia among US adults: A systematic review

John M. McLaughlin(Pfizer (United States)), David L. Swerdlow(Pfizer (United States)), Raúl Istúriz(Pfizer (United States)), Elizabeth Thoburn(Pfizer (United States)), Farid Khan(Pfizer (United States))

Vaccine

December 13, 2019

10.1016/j.vaccine.2019.10.101

Cited by 60

Related Papers

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

|The Lancet|2021|1.7k

Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009

|New England Journal of Medicine|2009|1.7k

H1N1 2009 influenza virus infection during pregnancy in the USA

|The Lancet|2009|1.4k

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

|The Lancet|2021|1.3k

<i>Escherichia coli</i>O157:H7 and the Hemolytic–Uremic Syndrome

|New England Journal of Medicine|1995|541